Ignite Creation Date:
2025-12-25 @ 2:44 AM
Ignite Modification Date:
2025-12-29 @ 12:52 AM
Study NCT ID:
NCT06608433
Status:
RECRUITING
Last Update Posted:
2025-02-11
First Post:
2024-09-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function
Sponsor:
University Hospital, Basel, Switzerland
Organization:
Study Overview
Official Title:
Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function - the PIANO Study
Status:
RECRUITING
Status Verified Date:
2025-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PIANO
Brief Summary:
This study aims to investigate the effects of a single dose of the glucagon-like 1 receptor agonist semaglutdie/Rybelsus on the hypothalamo-pituitary-adrenal axis, thus cortisol levels and other stresshormones in healthy males.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: